Immunocore Holdings plc American Depositary Shares
$31.59
-$0.18 (-0.58%)
$31.14Day Range$32.04
Key Statistics
Market Cap
$1.64B
Shares Outstanding
51.5M
Primary Exchange
XNAS
Currency
USD
Type
ADRC
IPO Date
Feb 5, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$31.67
Day High
$32.04
Day Low
$31.14
Volume
460.3K
VWAP
$31.45
Prev Close
$31.77
Transactions
--
Acc. Volume
--
About Immunocore Holdings plc American Depositary Shares
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)SIC 2836524 employees90 PARK DRIVE, OXFORDSHIRE, X0, OX14 4RY01235 5430281IPO Feb 5, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001671927
- Composite FIGI
- BBG00YYCXFB9
- Share Class FIGI
- BBG00YYCXG54
- Ticker Root
- IMCR
- SIC Code
- 2836
About Immunocore Holdings plc American Depositary Shares (IMCR) Stock
Immunocore Holdings plc American Depositary Shares (IMCR) closed the 2026-09-16 session at $31.59, down 0.58% versus the previous close (-0.18). The stock opened at $31.67 and traded between $31.14 and $32.04 during that session. Session trading volume was 460K shares. The volume-weighted average price (VWAP) is $31.45.
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
Immunocore Holdings plc American Depositary Shares has a market capitalization of $1.64 billion. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. IMCR is listed on the XNAS exchange. The company employs approximately 524 people. Immunocore Holdings plc American Depositary Shares is headquartered in OXFORDSHIRE, X0. The recorded listing date is 2021-02-05.
On this page you can find market IMCR stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.